Change Healthcare Canada Company recalls Horizon Cardiology Hemo. Version 12.2.
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- A potential issue has been identified in Change Healthcare Cardiology Hemo where incorrect data entry can lead to inaccurate hemodynamic calculations, potentially resulting in misdiagnosis and inappropriate treatment. This issue occurs when the unit of measurement (UOM) for hemoglobin is configured in a way that differs from the users understanding.
- Products
-
- Horizon Cardiology Hemo. Version 12.2.
- Where it was sold
-
Worldwide distribution - US Nationwide and the countries of Australia, Canada, Germany, Ireland, Israel, United Kingdom.
Nationwide
- Units affected
- 3 systems
- About this recall
- Horizon Cardiology Hemo. Version 12.2.